Literature DB >> 9862674

Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor.

F Dong1, X Liu, J P de Koning, I P Touw, L Hennighausen, A Larner, P M Grimley.   

Abstract

In a manner similar to many other cytokines, treatment of cells with granulocyte CSF (G-CSF) has been shown to induce the tyrosine phosphorylation of the STAT proteins. Activation of Stat1 and Stat5 by G-CSF requires the membrane-proximal cytoplasmic domain of the receptor, including box1 and box2, while G-CSF-stimulated tyrosine phosphorylation of Stat3 also requires a region distal to box 2. In this study, we show that although the membrane-proximal 55 amino acids of the G-CSF receptor are sufficient for activation of Stat5, the maximal rate of Stat5 activation requires an additional 30 amino acids of the cytoplasmic domain. In contrast, the distal carboxyl-terminal region of the receptor appears to down-regulate Stat5 activation in that deletion of this carboxyl terminus results in increased amplitude and prolonged duration of Stat5 activation by G-CSF. Significantly, expression of a truncated dominant-negative Stat5 protein in hemopoietic cells not only inhibits G-CSF-dependent cell proliferation, but also suppresses cell survival upon G-CSF withdrawal. We further show that a potential protein tyrosine phosphatase may play a critical role in the down-regulation of G-CSF-stimulated Stat5 activation. These results demonstrate that two distinct cytoplasmic regions of the G-CSF receptor are involved in the regulation of the intensity and duration of Stat5 activation, and that Stat5 may be an important player in G-CSF-mediated cell proliferation and survival.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862674

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.

Authors:  Yaling Qiu; Yangyang Zhang; Nan Hu; Fan Dong
Journal:  J Biol Chem       Date:  2017-01-10       Impact factor: 5.157

Review 2.  Innate immune regulation by STAT-mediated transcriptional mechanisms.

Authors:  Haiyan S Li; Stephanie S Watowich
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

3.  Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation.

Authors:  Haijiao Zhang; Cody Coblentz; Kevin Watanabe-Smith; Sophie Means; Jasmine Means; Julia E Maxson; Jeffrey W Tyner
Journal:  J Biol Chem       Date:  2018-03-23       Impact factor: 5.157

4.  Bortezomib inhibits STAT5-dependent degradation of LEF-1, inducing granulocytic differentiation in congenital neutropenia CD34(+) cells.

Authors:  Kshama Gupta; Inna Kuznetsova; Olga Klimenkova; Maksim Klimiankou; Johann Meyer; Malcolm A S Moore; Cornelia Zeidler; Karl Welte; Julia Skokowa
Journal:  Blood       Date:  2014-01-06       Impact factor: 22.113

5.  Peroxiredoxin-controlled G-CSF signalling at the endoplasmic reticulum-early endosome interface.

Authors:  Karishma Palande; Onno Roovers; Judith Gits; Carola Verwijmeren; Yoshihito Iuchi; Junichi Fujii; Benjamin G Neel; Robert Karisch; Jan Tavernier; Ivo P Touw
Journal:  J Cell Sci       Date:  2011-11-01       Impact factor: 5.285

6.  Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor.

Authors:  Elaine M Sloand; Agnes S M Yong; Shakti Ramkissoon; Elena Solomou; Tullia C Bruno; Sonnie Kim; Monika Fuhrer; Sachiko Kajigaya; A John Barrett; Neal S Young
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-15       Impact factor: 11.205

7.  miR-155 is associated with the leukemogenic potential of the class IV granulocyte colony-stimulating factor receptor in CD34⁺ progenitor cells.

Authors:  HaiJiao Zhang; Lilia Goudeva; Stephan Immenschuh; Axel Schambach; Julia Skokowa; Britta Eiz-Vesper; Rainer Blasczyk; Constança Figueiredo
Journal:  Mol Med       Date:  2015-04-09       Impact factor: 6.354

Review 8.  Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.

Authors:  Athanasia D Panopoulos; Stephanie S Watowich
Journal:  Cytokine       Date:  2008-04-08       Impact factor: 3.861

9.  Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.

Authors:  A C Ward; Y M van Aesch; J Gits; A M Schelen; J P de Koning; D van Leeuwen; M H Freedman; I P Touw
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

Review 10.  IL-2 Signaling Axis Defects: How Many Faces?

Authors:  Filippo Consonni; Claudio Favre; Eleonora Gambineri
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.